Cargando...
Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome
BACKGROUND: Polycystic ovary syndrome (PCOS) is a complex condition with high risk for dyslipidemia, dysglycemia, venous thromboembolism, cardiovascular disease and metabolic syndrome. Because the combined oral contraceptive (COC) use has also been associated with impaired fasting glucose, insulin r...
Guardado en:
| Publicado en: | Reprod Biol Endocrinol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5721684/ https://ncbi.nlm.nih.gov/pubmed/29216881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12958-017-0313-y |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|